The carboxylic acid-primary amide supramolecular heterosynthon is exploited for the generation of pharmaceutical co-crystals that contain two active pharmaceutical ingredients that are polymorphic in their pure forms.

Download full-text PDF

Source
http://dx.doi.org/10.1039/b501304fDOI Listing

Publication Analysis

Top Keywords

pharmaceutical co-crystals
8
active pharmaceutical
8
pharmaceutical ingredients
8
crystal engineering
4
pharmaceutical
4
engineering pharmaceutical
4
co-crystals polymorphic
4
polymorphic active
4
ingredients carboxylic
4
carboxylic acid-primary
4

Similar Publications

Natural products are ligands and in vitro inhibitors of Alzheimer's disease (AD) tau. Dihydromyricetin (DHM) bears chemical similarity to known natural product tau inhibitors. Despite having signature polyphenolic character, DHM is ostensibly hydrophobic owing to intermolecular hydrogen bonds that shield hydrophilic phenols.

View Article and Find Full Text PDF

Predicting the Thermodynamic Solubility and Stability of Co-crystals and Eutectics of Febuxostat by using a Thermodynamic Model involving Flory Huggins Interaction Parameter.

AAPS PharmSciTech

November 2024

Division of Pharmaceutical Sciences, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, 75 Dekalb Avenue, HS Bldg. 612, Brooklyn, NY, 11201, USA.

A method is presented for determining the thermodynamic (equilibrium) solubility of a drug in coformer for the non-covalent derivative (NCD) systems i.e. eutectics/co-crystals.

View Article and Find Full Text PDF

Insights into pharmaceutical co-crystallization using coherent Raman microscopy.

J Pharm Sci

January 2025

Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5E, 00790 Helsinki, Finland. Electronic address:

Article Synopsis
  • This study focuses on the process of creating co-crystals of active pharmaceutical ingredients (APIs) and highlights the importance of understanding co-crystallization behaviors under different conditions.
  • The researchers utilized two advanced imaging techniques, narrowband CARS and hyperspectral SRS, to observe co-crystallization in real-time, revealing key differences in component identification and overall co-crystal formation.
  • The findings provide new insights into the co-crystallization process, including unexpected trace forms and the influence of ethanol content on co-crystal stability during milling.
View Article and Find Full Text PDF

This survey provides a comprehensive analysis of solid form screens for 476 new chemical entities (NCEs) conducted at Pharmaron from 2016 to 2023. The findings from this survey reveal notable trends in polymorphism, salt formation, crystallization behavior and molecular weight (MW) distribution of the NCEs evaluated. Most solid form screens were conducted to select the preferred solid form for Investigational New Drug (IND) enabling projects, others were for candidate selection or late-stage development.

View Article and Find Full Text PDF

Developing a switch "OFF-ON" fluorescent probe for detection of melamine based on doubly-protected red emissive copper nanoclusters mediated by Hg ions.

Spectrochim Acta A Mol Biomol Spectrosc

February 2025

Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University, Assiut, Egypt. Electronic address:

Melamine, often used as an adulterant in infants' formula due to its high protein content, can be harmful when ingested in large amounts, leading to the formation of cyanurate-melamine co-crystals in infants and potentially causing kidney damage. In this study, we introduce a fluorescent method for the selective and reliable detection of melamine in milk and infants' formula. The fluorescent probe comprises copper nanoclusters (Cu NCs) functionalized with thiosalicylic acid (TSA) and polyvinylpyrrolidone (PVP) as double-protecting ligands.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!